Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells – blocking the energy supply T cells depend on. The work points toward a promising new immunotherapy approach for ovarian cancer.
A new system can accurately assess the chromosomal status of in vitro-fertilized embryos using only time-lapse video images of the embryos and maternal age, according to a study from investigators at Weill Cornell Medicine.
Investigators from Weill Cornell Medicine have discovered a defense mechanism that protects skin cancer cells from oxidative stress and helps them spread.
Professors Dr. Silvia Formenti and Dr. Massimo Loda have been elected to the National Academy of Medicine, in recognition of outstanding professional achievement and major contributions to the advancement of the medical sciences.
The fireside chat was part of a two-day visit by Dr. Robert M. Califf, commissioner of the U.S. Food and Drug Administration, who focused on medicine and health care innovations.
A study from Weill Cornell Medicine provides new insights into a pair of proteins and their opposing functions in regulating the interferon response in hepatic stellate cells, a critical immune component in the liver’s fight against tumors.
The findings could lead to new treatments targeting a particular protein to better manage inflammation in patients who don’t respond well to existing therapies.
A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, the Rockefeller University and the Icahn School of Medicine at Mount Sinai.
